Get the Stockscreener App
1.015
5.73%
0.055
Abpro Holdings Inc stock is traded at $1.015, with a volume of 2,704.
It is up +5.73% in the last 24 hours and down -36.96% over the past month.
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.
See More
Previous Close:
$0.96
Open:
$0.95
24h Volume:
2,704
Relative Volume:
0.00
Market Cap:
$57.23M
Revenue:
-
Net Income/Loss:
$-8.09M
P/E Ratio:
-6.2732
EPS:
-0.1618
Net Cash Flow:
$-8.31M
1W Performance:
-9.38%
1M Performance:
-36.96%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.95
$1.1045
1-Week Range:
$0.9005
$1.15
52-Week Range:
$0.9005
$5.13
Abpro Holdings Inc Stock (ABP) Company Profile
Name
Abpro Holdings Inc
Sector
Industry
Phone
248-890-7200
Address
6 ST JOHNS LANE, FLOOR 5, NEW YORK
Compare ABP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABP
Abpro Holdings Inc
|
1.015 | 57.23M | 0 | -8.09M | -8.31M | -0.1618 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.90 | 125.43B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
713.30 | 76.60B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.21 | 39.57B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.94 | 35.33B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.91 | 28.08B | 3.30B | -501.07M | 1.03B | -2.1146 |
Abpro Holdings Inc Stock (ABP) Latest News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Stock market news: Abpro Holdings -52.75%, Traws Pharma -42.47% among biggest losers during mid day trading - Business Upturn
Stock market news: Nxu surged by 276.55% while Abpro Holdings climbed by 136.32% during mid day trading - Business Upturn
Stock market today: Abpro Holdings -42.09%, Traws Pharma -39.26% among biggest losers in early trading - Business Upturn
Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing - The Manila Times
Abpro Holdings Debuts on Nasdaq with $60M+ Funding Package to Advance Cancer Therapy Pipeline - StockTitan
Atlantic Coastal Acquisition Corp. II Dismisses Independent Registered Public Accounting Firm - Defense World
Abpro Holdings engages new accounting firm By Investing.com - Investing.com Canada
Abpro Holdings engages new accounting firm - Investing.com
Abpro Holdings Inc Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Abpro Holdings Inc Rings the Closing Bell - Nasdaq
ABP stock touches 52-week low at $2.4 amid market challenges - Investing.com
Abpro Holdings announces CFO departure By Investing.com - Investing.com Canada
Abpro Holdings announces CFO departure - Investing.com
Abpro Holdings announces key post-merger developments - Investing.com
Abpro Holdings announces key post-merger developments By Investing.com - Investing.com Nigeria
Abpro Holdings Inc (ABP) reports earnings - Quartz
Abpro Announces Closing of Business Combination with Atlantic Coastal Acquisition Corp. II - PR Newswire
Abpro Holdings Completes Merger, Starts Nasdaq Trading - TipRanks
Atlantic Coastal Acquisition Corp. II Enters into Forward Purchase Agreement with Abpro Corporation - Defense World
Atlantic Coastal Acquisition Corp. II Corrects Typographical Error in Previous Reports on Business Combination with Abpro - Defense World
Atlantic Coastal Acquisition Corp. II Enters into Non-Redemption Agreement with Abpro Corp On November 5, 2024, Atlantic Coastal Acquisition Corp. II (NASDAQ: ACABU) disclosed in an 8-K filing a significant development regarding its proposed - Defense World
424B3 - SEC.gov
Atlantic Coastal Acquisition Corp. II amends business combination agreement - Investing.com
Atlantic Coastal enters key agreements ahead of merger - Investing.com
NASDAQ – Stock Price, Charts and News Today - BNN Bloomberg
US Share Prices on London South East, Share Prices on Cboe stocks - London South East
Atlantic Coastal II Files Proxy on $500M Abpro Deal - DealFlow's SPAC News
ABPAbpro Holdings, Inc Latest Stock News & Market Updates - StockTitan
PR News | Matter Reps Abpro as Biotech Goes PublicMon., Sep. 25, 2023 - O'Dwyer's PR News
Antibody biotech Abpro taps SPAC to get back on Nasdaq track 5 years after axed IPO - Fierce Biotech
Abpro to Become Publicly Traded via Merger with Atlantic Coastal Acquisition Corp. II - Business Wire
Celltrion/Abpro, Merck/Nerviano and more Unite against Cancer - BioSpace
These Woburn Businesses Got PPP Loans Over $150,000 - Woburn, MA Patch
Biodistribution and Dosimetry of Intraventricularly Administered - Journal of Nuclear Medicine
Abpro Holdings Inc Stock (ABP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
3.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):